Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Lidocaine patch transdermal - D. Western Therapeutics Institute/MEDRx

Next Previous
Drug Profile

Lidocaine patch transdermal - D. Western Therapeutics Institute/MEDRx

Alternative Names: Bondlido; DW-5LBT; Lidocaine Patch 20% - MEDRx; Lydolyte; Lydolyte®; MRX 5LBT

Latest Information Update: 10 Sep 2026

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator D. Western Therapeutics Institute; MEDRx
  • Developer MEDRx
  • Class Acetanilides; Amines; Class Ib antiarrhythmics; Ear disorder therapies; Local anaesthetics; Non-opioid analgesics; Small molecules
  • Mechanism of Action Sodium channel antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Registered Neuropathic pain

Most Recent Events

  • 25 Sep 2025 Registered for Neuropathic pain in USA (Transdermal)
  • 25 Sep 2025 D Western Theraputics Institute plans to begin sales of Lidocaine patch transdermal in US in the first half of 2026
  • 11 Aug 2023 Chemical structure information added

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top